Display options
Cite
Irani J. Intermittent androgen suppression in the management of prostate cancer: a phase II comparative study. Prostate Cancer Prostatic Dis. 2000;3:S20doi: 10.1038/sj.pcan.4500444.
Irani, J. (2000). Intermittent androgen suppression in the management of prostate cancer: a phase II comparative study. Prostate cancer and prostatic diseases, 3S20. https://doi.org/10.1038/sj.pcan.4500444
Irani, J. "Intermittent androgen suppression in the management of prostate cancer: a phase II comparative study." Prostate cancer and prostatic diseases vol. 3 (2000): S20. doi: https://doi.org/10.1038/sj.pcan.4500444
Irani J. Intermittent androgen suppression in the management of prostate cancer: a phase II comparative study. Prostate Cancer Prostatic Dis. 2000 Dec;3:S20. doi: 10.1038/sj.pcan.4500444. PMID: 12497130.
Copy Download .nbib Format: NLM
Share it on

Prostate Cancer Prostatic Dis. 2000 Dec;3:S20. doi: 10.1038/sj.pcan.4500444.

Intermittent androgen suppression in the management of prostate cancer: a phase II comparative study.

Prostate cancer and prostatic diseases

J Irani

Affiliations

  1. Centre Hospitalier Universitaire, Poitiers, France.

PMID: 12497130 DOI: 10.1038/sj.pcan.4500444

[No abstract available.]

Publication Types